Form 4 for TECX Tectonic Therapeutic, Inc.
Accepted 2023-01-26 00:00:00 ET · period of report 2022-12-28 · accession 0001127602-23-002332 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-26 | 2022-12-28 | TECX | MACKAY GEOFFREY | Pres, CEO, Dir | G - Gift | $0.00 | -245.1K | 142.0K | -63% | $0 |
| DI | 2023-01-26 | 2022-12-28 | TECX | MACKAY GEOFFREY | Pres, CEO, Dir | G - Gift | $0.00 | +245.1K | 445.1K | +123% | $0 |
| D | 2023-01-26 | 2023-01-24 | TECX | MACKAY GEOFFREY | Pres, CEO, Dir | M - OptEx | $0.91 | +46.0K | 188.0K | +32% | +$41.9K |
| D | 2023-01-26 | 2023-01-24 | TECX | MACKAY GEOFFREY | Pres, CEO, Dir | M - OptEx | $0.00 | -46.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-28 | G | D | 245,123 | $0.00 | 142,013 | D By The Geoff R. MacKay Irrevocable Trust | — | — | (F1) This transaction was a bona fide gift of common stock to The Geoff R. MacKay Irrevocable Trust. The reporting person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. |
| 2 | Common | Common Stock | 2022-12-28 | G | A | 245,123 | $0.00 | 445,123 | I | — | — | (F1) This transaction was a bona fide gift of common stock to The Geoff R. MacKay Irrevocable Trust. The reporting person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. |
| 3 | Common | Common Stock | 2023-01-24 | M | A | 45,999 | $0.91 | 188,012 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2023-01-24 | M | D | 45,999 | $0.00 | 0 | D | $0.91 · — to 2027-06-12 | 45,999 Common Stock | (F3) 25% of the shares vested on June 13, 2018, and the remaining 75% vested in equal monthly installments thereafter over a three-year period. |